Cisplatin/5-fluorouracil (CF) versus carboplatin/paclitaxel (CT) chemoradiotherapy (CRT) for locoregionally advanced esophageal cancer (LAEC).

M Marquardt(University of Iowa Hospitals and Clinics), John M. Watkins(Radiation Oncology Associates), John M. Buatti(University of Iowa), Carryn M. Anderson(University of Iowa Hospitals and Clinics), Sarah L. Mott(University of Iowa), Kalpaj R. Parekh(University of Iowa), Gerald H. Clamon(University of Iowa), Muhammad Furqan(University of Iowa), Bryan G. Allen(University of Iowa Hospitals and Clinics)
Journal of Clinical Oncology
February 1, 2017
Cited by 1


Related Papers